Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
No QoL Downside With Adding Nivo to Chemo in Urothelial Cancer
BARCELONA, Spain — Health-related quality of life (HRQoL) is not further compromised by the addition of nivolumab (Opdivo) immunotherapy to first-line cisplatin-based chemotherapy in patients with unresectable or metastatic urothelial carcinoma, according to an analysis of a phase 3 randomized…
English